Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts
- PMID: 23249249
- PMCID: PMC3566540
- DOI: 10.1042/BSR20120104
Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts
Abstract
NCLs (neuronal ceroid lipofuscinoses) form a group of eight inherited autosomal recessive diseases characterized by the intralysosomal accumulation of autofluorescent pigments, called ceroids. Recent data suggest that the pathogenesis of NCL is associated with the appearance of fragmented mitochondria with altered functions. However, even if an impairement in the autophagic pathway has often been evoked, the molecular mechanisms leading to mitochondrial fragmentation in response to a lysosomal dysfunction are still poorly understood. In this study, we show that fibroblasts that are deficient for the TPP-1 (tripeptidyl peptidase-1), a lysosomal hydrolase encoded by the gene mutated in the LINCL (late infantile NCL, CLN2 form) also exhibit a fragmented mitochondrial network. This morphological alteration is accompanied by an increase in the expression of the protein BNIP3 (Bcl2/adenovirus E1B 19 kDa interacting protein 3) as well as a decrease in the abundance of mitofusins 1 and 2, two proteins involved in mitochondrial fusion. Using RNAi (RNA interference) and quantitative analysis of the mitochondrial morphology, we show that the inhibition of BNIP3 expression does not result in an increase in the reticulation of the mitochondrial population in LINCL cells. However, this protein seems to play a key role in cell response to mitochondrial oxidative stress as it sensitizes mitochondria to antimycin A-induced fragmentation. To our knowledge, our results bring the first evidence of a mechanism that links TPP-1 deficiency and oxidative stress-induced changes in mitochondrial morphology.
Figures









Similar articles
-
Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway.Hum Mol Genet. 2014 Apr 15;23(8):2005-22. doi: 10.1093/hmg/ddt596. Epub 2013 Nov 23. Hum Mol Genet. 2014. PMID: 24271013 Free PMC article.
-
An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.Clin Genet. 2009 Oct;76(4):372-82. doi: 10.1111/j.1399-0004.2009.01214.x. Clin Genet. 2009. PMID: 19793312
-
A novel CLN2/TPP1 mutation in a patient with late infantile neuronal ceroid lipofuscinosis.Neurol Sci. 2015 Oct;36(10):1917-9. doi: 10.1007/s10072-015-2272-4. Epub 2015 Jun 2. Neurol Sci. 2015. PMID: 26032578 No abstract available.
-
Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.Cell Mol Life Sci. 2011 Feb;68(3):453-74. doi: 10.1007/s00018-010-0468-6. Epub 2010 Aug 1. Cell Mol Life Sci. 2011. PMID: 20680390 Free PMC article. Review.
-
Neuronal ceroid lipofuscinoses and possible pathogenic mechanism.Mol Genet Metab. 2000 Sep-Oct;71(1-2):195-206. doi: 10.1006/mgme.2000.3057. Mol Genet Metab. 2000. PMID: 11001811 Review.
Cited by
-
Benchmarking Nanopore Sequencing for CLN2 (TPP1) Mutation Detection: Integrating Rapid Genomics and Orthogonal Validation for Precision Diagnostics.Int J Mol Sci. 2025 May 23;26(11):5037. doi: 10.3390/ijms26115037. Int J Mol Sci. 2025. PMID: 40507848 Free PMC article.
-
Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease.Hum Mutat. 2019 Nov;40(11):1924-1938. doi: 10.1002/humu.23860. Epub 2019 Jul 26. Hum Mutat. 2019. PMID: 31283065 Free PMC article.
-
Chromosome-level genomes of two Bracteacoccaceae highlight adaptations to biocrusts.Nat Commun. 2025 Feb 10;16(1):1492. doi: 10.1038/s41467-025-56614-2. Nat Commun. 2025. PMID: 39929813 Free PMC article.
-
Glycolytic switch in response to betulinic acid in non-cancer cells.PLoS One. 2014 Dec 22;9(12):e115683. doi: 10.1371/journal.pone.0115683. eCollection 2014. PLoS One. 2014. PMID: 25531780 Free PMC article.
-
Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).Front Cell Dev Biol. 2022 Feb 16;10:812728. doi: 10.3389/fcell.2022.812728. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35252181 Free PMC article. Review.
References
-
- Sohar I., Sleat D. E., Jadot M., Lobel P. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models. J. Neurochem. 1999;73:700–711. - PubMed
-
- Bernardini F., Warburton M. J. Lysosomal degradation of cholecystokinin-(29–33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis. Biochem. J. 2002;366:521–529. - PMC - PubMed
-
- Ezaki J., Tanida I., Kanehagi N., Kominami E. A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase. J. Neurochem. 1999;72:2573–2582. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous